Steward Partners Investment Advisory LLC Has $2.89 Million Stake in Sanofi (NASDAQ:SNY)

Steward Partners Investment Advisory LLC lifted its position in shares of Sanofi (NASDAQ:SNY) by 12.6% during the fourth quarter, Holdings Channel.com reports. The firm owned 59,973 shares of the company’s stock after purchasing an additional 6,701 shares during the period. Steward Partners Investment Advisory LLC’s holdings in Sanofi were worth $2,893,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Synergy Asset Management LLC acquired a new position in Sanofi during the fourth quarter worth $25,000. McClarren Financial Advisors Inc. raised its holdings in shares of Sanofi by 952.6% in the 4th quarter. McClarren Financial Advisors Inc. now owns 600 shares of the company’s stock worth $28,000 after acquiring an additional 543 shares during the last quarter. Sunbelt Securities Inc. raised its holdings in shares of Sanofi by 72.1% in the 3rd quarter. Sunbelt Securities Inc. now owns 747 shares of the company’s stock worth $43,000 after acquiring an additional 313 shares during the last quarter. Sierra Ocean LLC acquired a new stake in shares of Sanofi in the 4th quarter worth about $44,000. Finally, Versant Capital Management Inc acquired a new stake in shares of Sanofi in the 4th quarter worth about $54,000. 14.04% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on SNY. StockNews.com downgraded Sanofi from a “buy” rating to a “hold” rating in a research note on Thursday, December 12th. Sanford C. Bernstein raised Sanofi to a “strong-buy” rating in a research report on Thursday, January 30th. Finally, Deutsche Bank Aktiengesellschaft raised Sanofi from a “sell” rating to a “hold” rating in a research report on Thursday, January 30th. Two analysts have rated the stock with a hold rating, one has issued a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, Sanofi currently has an average rating of “Buy” and an average target price of $60.00.

Sanofi Trading Down 0.3 %

NASDAQ:SNY opened at $59.25 on Friday. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.14 and a current ratio of 1.46. The firm has a market cap of $150.37 billion, a price-to-earnings ratio of 23.80, a price-to-earnings-growth ratio of 1.01 and a beta of 0.58. Sanofi has a 52 week low of $45.22 and a 52 week high of $59.72. The firm has a 50-day moving average price of $52.44 and a two-hundred day moving average price of $52.73.

Sanofi (NASDAQ:SNY) last issued its quarterly earnings results on Thursday, January 30th. The company reported $0.70 EPS for the quarter, meeting analysts’ consensus estimates of $0.70. Sanofi had a return on equity of 25.61% and a net margin of 12.77%. On average, equities analysts expect that Sanofi will post 4.36 earnings per share for the current fiscal year.

Sanofi Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.